GRAIL (GRAL) Projected to Post Quarterly Earnings on Tuesday

Key Points

• GRAIL is set to release its Q2 2025 earnings results on August 12, with analysts forecasting a loss of ($3.14) per share and revenue of $37.57 million.
• In its last earnings report, GRAIL beat estimates by reporting ($3.10) EPS, despite a negative net margin of 1,464.53% and revenue lower than expected at $31.84 million.
• Insider trading activity has seen significant sales, with the CFO selling 8,000 shares for approximately $311,440, indicating a 2.72% decrease in ownership.

GRAIL (NASDAQ:GRAL - Get Free Report) is expected to be issuing its Q2 2025 quarterly earnings data after the market closes on Tuesday, August 12th. Analysts expect the company to announce earnings of ($3.14) per share and revenue of $37.57 million for the quarter.

GRAIL (NASDAQ:GRAL - Get Free Report) last announced its earnings results on Tuesday, May 13th. The company reported ($3.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.03) by $0.93. The business had revenue of $31.84 million for the quarter, compared to analysts' expectations of $35.80 million. GRAIL had a negative return on equity of 17.99% and a negative net margin of 1,464.53%. On average, analysts expect GRAIL to post $-15 EPS for the current fiscal year and $-13 EPS for the next fiscal year.

GRAIL Price Performance

NASDAQ GRAL traded down $0.14 during midday trading on Friday, hitting $32.82. 645,753 shares of the company traded hands, compared to its average volume of 983,715. The company has a market cap of $1.18 billion, a PE ratio of -0.54 and a beta of 3.26. The company's 50-day simple moving average is $40.70 and its 200-day simple moving average is $36.09. GRAIL has a 52 week low of $12.33 and a 52 week high of $63.99.

Wall Street Analysts Forecast Growth

Separately, Canaccord Genuity Group increased their target price on GRAIL from $32.00 to $43.00 and gave the company a "buy" rating in a research report on Wednesday, May 14th.

Insider Activity

In other GRAIL news, President Joshua J. Ofman sold 9,692 shares of the stock in a transaction dated Monday, June 30th. The stock was sold at an average price of $52.00, for a total transaction of $503,984.00. Following the sale, the president directly owned 492,076 shares of the company's stock, valued at approximately $25,587,952. This trade represents a 1.93% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Aaron Freidin sold 8,000 shares of the stock in a transaction dated Tuesday, July 15th. The stock was sold at an average price of $38.93, for a total value of $311,440.00. Following the sale, the chief financial officer directly owned 286,020 shares in the company, valued at $11,134,758.60. This represents a 2.72% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 357,492 shares of company stock worth $17,645,718. Insiders own 1.85% of the company's stock.

Institutional Investors Weigh In On GRAIL

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in GRAIL by 37.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 92,465 shares of the company's stock worth $2,362,000 after purchasing an additional 25,177 shares in the last quarter. Royal Bank of Canada lifted its stake in GRAIL by 17.7% in the 1st quarter. Royal Bank of Canada now owns 88,082 shares of the company's stock worth $2,250,000 after purchasing an additional 13,264 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in GRAIL by 28.2% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,835 shares of the company's stock worth $76,000 after purchasing an additional 623 shares in the last quarter. Finally, NewEdge Advisors LLC raised its position in shares of GRAIL by 390.3% during the 1st quarter. NewEdge Advisors LLC now owns 1,760 shares of the company's stock valued at $45,000 after buying an additional 1,401 shares during the period.

GRAIL Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.